5-carbazol-9-yl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;5-carbazol-9-yl-2-[3-(2-pyridin-2-yl-1H-carbazol-1-id-9-yl)benzene-2-id-1-yl]-1,3-oxazole;5-carbazol-9-yl-2-[9-(3-pyrido[2,3-b]indol-9-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;palladium(2+);bis(platinum(2+))
C120H69N13O3PdPt2 — CID 159418418
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-carbazol-9-yl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;5-carbazol-9-yl-2-[3-(2-pyridin-2-yl-1H-carbazol-1-id-9-yl)benzene-2-id-1-yl]-1,3-oxazole;5-carbazol-9-yl-2-[9-(3-pyrido[2,3-b]indol-9-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;palladium(2+);bis(platinum(2+))
5-carbazol-9-yl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;5-carbazol-9-yl-2-[3-(2-pyridin-2-yl-1H-carbazol-1-id-9-yl)benzene-2-id-1-yl]-1,3-oxazole;5-carbazol-9-yl-2-[9-(3-pyrido[2,3-b]indol-9-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;palladium(2+);bis(platinum(2+)) (PubChem CID 159418418) has the molecular formula C120H69N13O3PdPt2 and a molecular weight of 2237.54 g/mol. Its IUPAC name is 5-carbazol-9-yl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;5-carbazol-9-yl-2-[3-(2-pyridin-2-yl-1H-carbazol-1-id-9-yl)benzene-2-id-1-yl]-1,3-oxazole;5-carbazol-9-yl-2-[9-(3-pyrido[2,3-b]indol-9-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;palladium(2+);bis(platinum(2+)).
Molecular Properties
| Compound Name | 5-carbazol-9-yl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;5-carbazol-9-yl-2-[3-(2-pyridin-2-yl-1H-carbazol-1-id-9-yl)benzene-2-id-1-yl]-1,3-oxazole;5-carbazol-9-yl-2-[9-(3-pyrido[2,3-b]indol-9-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;palladium(2+);bis(platinum(2+)) |
|---|---|
| PubChem CID | 159418418 |
| Molecular Formula | C120H69N13O3PdPt2 |
| Molecular Weight | 2237.54 g/mol |
| Exact Mass | 2235.40 |
| IUPAC Name | 5-carbazol-9-yl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;5-carbazol-9-yl-2-[3-(2-pyridin-2-yl-1H-carbazol-1-id-9-yl)benzene-2-id-1-yl]-1,3-oxazole;5-carbazol-9-yl-2-[9-(3-pyrido[2,3-b]indol-9-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-oxazole;palladium(2+);bis(platinum(2+)) |
| SMILES | [Pd+2].[Pt+2].[Pt+2].[c-]1c(-c2ccccn2)cccc1-n1c2[c-]c(-c3ncc(-n4c5ccccc5c5ccccc54)o3)ccc2c2ccccc21.[c-]1c(-c2ncc(-n3c4ccccc4c4ccccc43)o2)cccc1-n1c2[c-]c(-c3ccccn3)ccc2c2ccccc21.[c-]1c(-n2c3[c-]c(-c4ncc(-n5c6ccccc6c6ccccc65)o4)ccc3c3ccccc32)cccc1-n1c2ccccc2c2cccnc21 |
| InChI | InChI=1S/C44H25N5O.2C38H22N4O.Pd.2Pt/c1-5-18-37-33(15-1)35-23-22-28(44-46-27-42(50-44)49-39-20-7-2-13-31(39)32-14-3-8-21-40(32)49)25-41(35)47(37)29-11-9-12-30(26-29)48-38-19-6-4-16-34(38)36-17-10-24-45-43(36)48;1-4-16-33-30(14-1)31-20-19-25(32-15-7-8-21-39-32)23-36(31)41(33)27-11-9-10-26(22-27)38-40-24-37(43-38)42-34-17-5-2-12-28(34)29-13-3-6-18-35(29)42;1-4-16-33-30(14-1)31-20-19-26(23-36(31)41(33)27-11-9-10-25(22-27)32-15-7-8-21-39-32)38-40-24-37(43-38)42-34-17-5-2-12-28(34)29-13-3-6-18-35(29)42;;;/h1-24,27H;2*1-21,24H;;;/q3*-2;3*+2 |
| InChIKey | DSGWWKKNTSQVQG-UHFFFAOYSA-N |
| XLogP | 29.02 |
| TPSA | 151.27 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 139 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2237.54 |
| LogP ≤ 5 | 29.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159418418 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.